{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T12:31:01Z","timestamp":1648643461599},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1007\/bf00053444","type":"journal-article","created":{"date-parts":[[2004,10,31]],"date-time":"2004-10-31T06:32:30Z","timestamp":1099204350000},"page":"127-131","source":"Crossref","is-referenced-by-count":0,"title":["Serotonin antagonism reduces the adverse symptoms of beta blockade"],"prefix":"10.1007","volume":"4","author":[{"given":"Krishnarao","family":"Korlipara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"Beta-Blockers in Clinical Practice","year":"1988","unstructured":"Cruickshank JM, Pritchard BN, eds. Beta-Blockers in Clinical Practice. London: Churchill Livingstone, 1988."},{"key":"CR2","first-page":"539","volume":"2","author":"MRC Working Party on Mild to Moderate Hypertension","year":"1981","unstructured":"MRC Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981;2:539?543.","journal-title":"Lancet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.HYP.11.2.111","volume":"11","author":"P Vanhoutte","year":"1988","unstructured":"Vanhoutte P, Amory A, Birkenhagor W, et al. Serotonergic mechanisms in hypertension?focus on the effects of ketanserin. Hypertension 1988;11:111?133.","journal-title":"Hypertension"},{"issue":"Suppl 5","key":"CR4","first-page":"S529","volume":"5","author":"JF Turner","year":"1987","unstructured":"Turner JF, Gould SE, Welburn PJ, et al. The effect of antihypertensive treatment on the assesement of well-being in a general practice population. J Hypertens 1987; 5(Suppl 5):S529-S531.","journal-title":"J Hypertens"},{"key":"CR5","volume-title":"Nonparametric Statistics for the Behavioral Sciences","author":"S Seigel","year":"1956","unstructured":"Seigel S. Nonparametric Statistics for the Behavioral Sciences. Tokyo: McGraw-Hill Publishers, 1956."},{"issue":"Suppl 1","key":"CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2165\/00003495-198800361-00026","volume":"36","author":"K Korlipara","year":"1988","unstructured":"Korlipara K, Gould SE, Taylor NA, et al. Comparative trial of ketanserin or bendrofluazide as add-on therapy in hypertensive patients uncontrolled on a ?-blocker alone. Drugs 1988;36(Suppl 1):130?134.","journal-title":"Drugs"},{"issue":"1","key":"CR7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.75.1.204","volume":"75","author":"JB Kostis","year":"1987","unstructured":"Kostis JB, Rosen RC. Central nervous system effects of ?-adrenergic blocking drugs: The role of ancillary properties. Circulation 1987;75(1):204?212.","journal-title":"Circulation"},{"key":"CR8","unstructured":"Hammond G, Idzikowski C, Burton S, Jones R. The effects of chronic ritanserin treatment and withdrawal on sleep. Psychopharmacology 1988;96(Suppl):S295."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00572267","volume":"21","author":"DLF Dunleavy","year":"1971","unstructured":"Dunleavy DLF, Maclean AW, Oswald I. Debrisoquine, guanethidine, propranolol and human sleep. Psychopharmacology 1971;21:101?110.","journal-title":"Psychopharmacology"},{"key":"CR10","first-page":"416","volume":"93","author":"GI Idsikowski","year":"1987","unstructured":"Idsikowski GI, Cowen PJ, Nutt D, et al. The effects of chronic ritanserin treatment on sleep and neuroendocrino response to L-tryptophan. Psychopharmacology 1987;93:416?420.","journal-title":"Psychopharmacology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.298.6671.424","volume":"298","author":"The PACK Trial Group","year":"1989","unstructured":"The PACK Trial Group. Randomized trial of ketanserin for prevention of atherosclerotic complications. Br Med J 1989;298:424?430.","journal-title":"Br Med J"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"Coffman JD, Dormandy JA, Murray GD, et al. International study of ketanserin in Raynaud's phenomenon. Data presented at International Symposium on Serotonin From Cell Biology to Pharmacology and Therapeutics. Florence, Italy, March 1989.","DOI":"10.1016\/S0002-9343(89)80148-2"},{"key":"CR13","unstructured":"Tooke JE. Ketanserin and peripheral blood flow. In: Serotonin Antagonists in Hypertension ? Proceedings of an International Symposium. Birmingham, 30th May, 1985. Update-Siebert, 1985."},{"key":"CR14","first-page":"37","volume":"12","author":"IW Tomlinson","year":"1985","unstructured":"Tomlinson IW. Monitoring cutaneous circulation in Raynaud's phenomenon with observations on ketanserin. Adv Microcirculation 1985;12:37?52.","journal-title":"Adv Microcirculation"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365528609011123","volume":"21","author":"J Gustafsen","year":"1986","unstructured":"Gustafsen J, Lendord A, Raskow H, Boesby S. Ketanserin versus placebo in carcinoid syndrome. Scand J Gastroenterol 1986;21:816?818.","journal-title":"Scand J Gastroenterol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00053444\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T23:50:50Z","timestamp":1554249050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00053444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["BF00053444"],"URL":"https:\/\/doi.org\/10.1007\/bf00053444","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}